PATENT CLAIM ANALYSIS

Application Number: 16233890
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["514", "100000"]

Abstract:
The present invention relates to a glucagon derivative, a conjugate thereof, and a composition comprising the same, and a therapeutic use thereof, and in particular, for metabolic syndrome, hypoglycemia, and congenital hyperinsulinism.

Claim (Index 83):
A method for treating metabolic syndrome comprising administering the isolated peptide according to  claim 59 , or an isolated conjugate comprising a peptide moiety and a biocompatible material moiety which is linked to the peptide moiety, wherein the peptide moiety is the isolated peptide, to a subject in need thereof.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 98.0
- Lexical Diversity: 1.48148
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15740668', '13810999', '16024014', '15313501', '15086499']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8057079352573518
- 35 USC 102 Novelty (BERT): 0.614028501217673
- Combined Prediction Score: 0.786539991853384
- Mean Citation Score: 452.842674
- Max Citation Score: 747.8688
- Similarity Product: 476.3596800933837

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test